In the present study, we observed that these cut-points still allow a considerable proportion of patients with RA to be classified as remitters despite the presence of a significant SJC, namely up to 8 in DAS28-CRP remission and 13 in DAS28-ESR remission. This evidence concerns the gene ESR1 and rheumatoid arthritis.